Upgrading mass spectrometry for better proteomics analysis at Georgia Tech
Official title: Bruker timsTOF HT Mass Spectrometer to Support Proteomics Research in the Georgia Tech Core Facilities
Funded at Georgia Institute of Technology · NIH-11102381 · Data updated 2026-11-12
This study is all about getting a new, high-tech machine at Georgia Tech that will help scientists study proteins more accurately and efficiently, which will benefit various health research projects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $750,000 |
| NIH project number | 1S10OD038327-01 |
| Project ID | NIH-11102381 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals involved in NIH-funded proteomics studies, particularly those focused on understanding complex diseases at the molecular level.
✕Less likely to help
Patients who are not involved in research studies or those whose conditions are not being investigated through proteomics may not receive direct benefits from this research.
What this research studies
This project aims to enhance proteomics research capabilities at Georgia Tech by acquiring a state-of-the-art Bruker timsTOF HT mass spectrometer. This new instrument will replace outdated technology, allowing for more accurate and efficient analysis of proteins. The upgrade will support various NIH-funded projects and improve the quality of research conducted in the Systems Mass Spectrometry Core facility. By integrating advanced ion mobility spectrometry with mass spectrometry, the new system promises to deliver significant improvements in sensitivity and specificity for proteomics studies.
Why it matters
Potential benefit: If successful, this research could lead to more precise and reliable proteomics data, ultimately benefiting patients through improved understanding of diseases and better-targeted therapies.
How similar studies have gone: Previous research has shown success with similar mass spectrometry upgrades, indicating that this approach is backed by evidence of improved performance in proteomics analysis.
Where this research is happening
-
Georgia Institute of Technology
Atlanta, United States Active
Researchers
- Principal investigator: Torres, Matt Phillip — Georgia Institute of Technology
- Study coordinator: Torres, Matt Phillip
Related research
Other NIH-funded projects on the same topics.
-
Integrative AI tools to map protein sequences to structures and functions
A scientist team will develop advanced AI methods to better connect protein sequences, their 3D shapes, and how they work, using large biological data from sequencing and structures.
-
Robotic ultrasound-guided clot removal for stroke treatment
A new robot-assisted ultrasound system is being developed to help quickly reopen brain arteries during a stroke, with testing in patient-specific 3D-printed models and animal studies.
-
siRNA nanoparticle treatment to stop diabetic kidney damage
A new nanoparticle-delivered gene-silencing treatment aims to lower kidney inflammation in people with diabetes to help protect their kidneys.
-
Nanosensor blood test to spot early pancreatic cancer fingerprints
This project will use a nanosensor blood test to detect early-stage pancreatic cancer by reading a disease 'fingerprint' in patient serum.
-
Synergistic blood-brain barrier opening and targeted glioma treatment with pulsed electric fields
A new approach uses tiny, rapid electric pulses to safely disrupt the brain's protective barrier and enhance targeted treatment for malignant glioma.
-
Dexterous needle ablation for ventricular arrhythmia guided by MRI
A new MRI-guided, robot-assisted catheter delivers deeper heart tissue ablation to treat ventricular tachycardia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.